Portland, OR – According to filings with the U.S. Securities and Exchange Commission, Sonivate Medical is raising $3,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, James Hatlan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Sonivate Medical

Sonivate Medical develops and markets innovative ultrasound technology and participates in the world-wide $7 Billion market. The company’s technology opens new markets for ultrasound by extending its use especially with ease of use and preference for new users. Sonivate has been financially supported by grants from the US Department of Defense and private investors.

To learn more about Sonivate Medical, visit http://sonivate.com/

Contact:
James Hatlan, Chief Executive Officer
971-220-7871
jhatlan@sonivate.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved